Quantcast

Latest non-surgical treatment Stories

2014-08-22 23:08:06

MetroMD is a leading clinic in America and they specialize PRP Therapy to help people with hip problems and other injuries like ligament damage using non-surgical treatment. (PRWEB) August 22, 2014 Reacting to naysayers who are being skeptical about the success of Platelet Rich Plasma therapy (PRP), a top PRP therapy LA specialist has firmly stated that the new revolutionary PRP therapy has everything to do with practical well researched science and nothing to do with medical industry...

2014-05-21 08:28:42

NORWALK, Conn., May 21, 2014 /PRNewswire/ -- A newly published peer-reviewed study that examines Stretta(®) therapy, further confirms the long-term effectiveness of this non-surgical treatment for gastroesophageal reflux disease (GERD). The 8-year study published in Gastroenterology Research and Practice, entitled "Durability of Stretta Radiofrequency Treatment for GERD: Results of 8-Year Follow-Up" corroborates the findings of another recently published long-term study on Stretta...

2014-01-30 23:31:04

RB Spine Center has added Intervertebral Differential Dynamics (IDD) Therapy to its suite of non-surgical treatment options for chronic back and neck conditions. San Diego, CA (PRWEB) January 30, 2014 RB Spine Center, a pain management and rehabilitation center in San Diego, has announced the addition of Intervertebral Differential Dynamics (IDD) Therapy to its suite of non-surgical treatment options for chronic back and neck conditions. The facility has also added new members to its team...

2013-07-31 23:34:04

A pair of new studies indicate that most patients with rotator cuff injuries respond well to non-surgical treatment, and a key predictor of who benefits most from physical therapy may simply be who expects to. This is good news for those coping with rotator cuff injuries, the most common cause of shoulder pain and dysfunction in adults, according to Jeffrey Yormak, MD. Carmel, NY (PRWEB) July 31, 2013 A pair of new studies indicate that most patients with rotator cuff injuries respond...

2013-02-06 23:03:43

The Retina Group of New York (RGONY) with offices in Hicksville and Hauppauge, NY, has announced the availability of JETREA® (Ocriplasmin), the first non-surgical treatment for patients with symptomatic Vitreo-macular Adhesion (VMA) or Vitreo-macular Traction (VMT). Hicksville and Hauppauge, NY (PRWEB) February 06, 2013 The Retina Group of New York (RGONY) with offices in Hicksville and Hauppauge, NY, has announced the availability of JETREA® (Ocriplasmin), the first non-surgical...

2010-09-01 00:29:00

LEUVEN, Belgium, September 1, 2010 /PRNewswire-FirstCall/ -- - Data Presented at ASRS Confirm Previous Phase III Findings and Microplasmin's Potential to Transform the Treatment of Retinal Disorders ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer announces that its second Phase III trial evaluating microplasmin for the non-surgical treatment of...

2010-07-01 00:27:00

LEUVEN, Belgium, July 1, 2010 /PRNewswire-FirstCall/ -- ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that data from the second Phase III trial of microplasmin (TG-MV-007) for the non-surgical treatment of vitreomacular adhesion (VMA), are to be presented at the 28th Annual Meeting of the American Society of Retina Specialists (ASRS) and the 10th EURETINA Congress....

2010-06-07 00:28:00

LEUVEN, Belgium, June 7, 2010 /PRNewswire-FirstCall/ -- - Data Presented Show Microplasmin Cures Approximately 50% of Patients With Macular Hole ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the...

2010-04-20 00:30:00

LEUVEN, Belgium, April 20, 2010 /PRNewswire-FirstCall/ -- - Highly Significant Trial Result (p=0.003) Demonstrates the Potential of Microplasmin in the Treatment of Retinal Disease ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, vascular disease and cancer, announces that its first Phase III trial with microplasmin for the non-surgical treatment of eye disease has met its...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related